Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-006427

SVP, Chief Technical Officer sold 21,387 shares at $23.80 ($509,075)

  • SVP, Chief Technical Officer acquired 21,387 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-20 Exercise or conversion : show line 1 in the form +21,387 $7.14 $152,703 197,574 D
2020-05-20 Sale : show line 2 in the form −21,387 $23.80 $509,075 176,187 D
Open-market sales · 21,387 sh · avg $23.80 · $509,075

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-05-20 Exercise or conversion : show line 3 in the form Option to Purchase Common Stock −21,387 $7.14 2021-02-03 21,387 18,613 D
Loading xslF345X03/edgar.xml…